Vitrolife AB

Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company develops, manufactures, and distributes specialized products such as culture media, sperm processing solutions, and genetic testing services for IVF clinics and their patients worldwide. Its mission focuses on supporting IVF clinics to enhance treatment practices, improve fertility outcomes, and help patients navigate reproductive health challenges through reliable, high-quality solutions that promote successful pregnancies and satisfaction. Operating across three key geographical segments—EMEA, Americas, and APAC—with the majority of revenue from EMEA, Vitrolife AB serves clinics in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. Founded in 1994 and headquartered in Gothenburg, Sweden, the company employs over 1,100 people and maintains rigorous quality control standards that have set industry benchmarks for two decades. Vitrolife AB also offers comprehensive support through its Academy, including webinars, instructional materials, and customized training to optimize lab efficiency and IVF processes, positioning it as a pivotal player in the medical devices sector for fertility treatments.